title: Prior diagnosis and treatment of patients with normal results of methacholine challenge and unexplained respiratory symptoms.
abstract: OBJECTIVE
  Previous research indicates that asthma has been underdiagnosed. However, we suspect that recent widespread attention to the underdiagnosis of asthma has led to an overdiagnosis of asthma in some settings. We therefore sought to examine prior diagnosis and treatment of patients referred to our facility and subsequently found to have no objective evidence of variable airflow limitation.
  
  
  METHODS
  Retrospective chart review.
  
  
  METHODS
  Hospital-based asthma center.
  
  
  METHODS
  A referred sample of 263 patients in whom a methacholine challenge (MCC) was conducted after evaluation by our pulmonologists; complete medical histories were available.
  
  
  METHODS
  Prior respiratory diagnoses, duration of treatment with asthma medications, and diagnosis following assessment by our pulmonologists in 175 patients with a provocative concentration of the substance causing a 20% fall in FEV1 (PC20) greater than 8.0 mg/mL and 88 with a PC20 of 8.0 mg/mL or less.
  
  
  RESULTS
  Of those with a PC20 greater than 8 mg/mL, a diagnosis of asthma or possible asthma prior to the challenge study was recorded by their primary care physician in 129 patients (74%). One hundred sixty of 172 patients (88%) with a PC20 greater than 8 mg/mL were diagnosed as not having asthma by our pulmonologists; 109 of 172 patients (62%) had been previously treated with asthma medication(s). The mean duration of asthma treatment was 25.9+/- 56.3 months, and there was no significant difference in the duration of treatment between this group and those who had a PC20 of 8 mg/mL or less. Most of those treated received inhaled beta2-agonists and inhaled corticosteroids. Approximately 61% received two or more classes of medications.
  
  
  CONCLUSIONS
  The misdiagnosis of asthma occurs commonly in the referral practice of a tertiary care asthma center. The more frequent use of objective pulmonary function testing in primary practice might reduce the problem of delayed diagnosis and inappropriate therapy for respiratory symptoms.
authors.affiliation: Asthma Centre of The Toronto Hospital, University of Ontario, Canada.
authors.forename: D P
authors.initials: DP
authors.lastname: Joyce
authors.forename: K R
authors.initials: KR
authors.lastname: Chapman
authors.forename: S
authors.initials: S
authors.lastname: Kesten
mesh_terms: D001249:Asthma / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D016535:Bronchial Hyperreactivity / Q000503:physiopathology; D001985:Bronchial Provocation Tests; D003937:Diagnosis, Differential; D006801:Humans; D016210:Methacholine Chloride; D012189:Retrospective Studies
chemical_list: D016210:Methacholine Chloride